Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
414.98M | 458.73M | 467.35M | 408.62M | 327.75M | 323.67M | Gross Profit |
66.04M | 66.56M | 78.74M | 64.67M | 48.67M | 42.23M | EBIT |
45.65M | 46.27M | 59.07M | 45.80M | 32.55M | 23.87M | EBITDA |
47.35M | 53.56M | 62.32M | 49.16M | 35.88M | 24.67M | Net Income Common Stockholders |
39.24M | 40.77M | 50.15M | 37.41M | 27.35M | 18.70M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
114.93M | 104.91M | 79.37M | 48.77M | 35.59M | 16.23M | Total Assets |
286.51M | 274.53M | 250.13M | 207.02M | 178.80M | 152.06M | Total Debt |
571.00K | 1.13M | 2.17M | 867.00K | 2.51M | 5.18M | Net Debt |
-19.36M | -103.78M | -57.20M | -47.90M | -33.08M | -11.05M | Total Liabilities |
16.32M | 13.13M | 18.30M | 16.11M | 18.29M | 12.73M | Stockholders Equity |
270.18M | 261.39M | 231.83M | 190.92M | 160.51M | 139.33M |
Cash Flow | Free Cash Flow | ||||
35.65M | 35.00M | 40.60M | 21.86M | 28.22M | 16.97M | Operating Cash Flow |
37.87M | 36.50M | 40.79M | 22.52M | 28.68M | 17.41M | Investing Cash Flow |
-46.08M | 21.35M | -19.98M | -629.00K | -397.00K | -304.00K | Financing Cash Flow |
-12.33M | -12.31M | -10.20M | -8.71M | -8.91M | -21.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | HK$1.06B | 25.52 | 15.07% | 1.05% | -8.84% | -6.59% | |
75 Outperform | $86.41B | 17.04 | 13.76% | 8.11% | 1.23% | 1.58% | |
73 Outperform | HK$2.89B | 9.95 | 58.52% | 19.65% | -9.98% | -12.36% | |
69 Neutral | HK$183.00M | 11.78 | 2.85% | 2.62% | 13.26% | -18.81% | |
61 Neutral | $2.83B | 10.89 | 0.41% | 9.34% | 5.96% | -21.31% | |
58 Neutral | HK$98.80M | 12.67 | 5.22% | 3.95% | 1.74% | -46.43% | |
34 Underperform | HK$66.39M | ― | ― | -31.70% | -85.40% |